Physician profile
Thomas A Simpson
NPI 1285672428
$2,142.14
in general payments reported to CMS, 2019-2025
24 companies · $881 in 2025
The $881 reported for 2025 was more than what 79% of Otolaryngology/Facial Plastic Surgery providers received nationally (typical 2025 total: $305).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $252 · 2020: $75.80 · 2021: $57.38 · 2022: $137 · 2023: $306 · 2024: $434 · 2025: $881.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,620.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,620.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $290.71 | 2019-2025 | Dupixent |
| Genzyme Corporation | $251.53 | 2019-2025 | |
| Medtronic, INC. | $227.56 | 2024-2025 | Stealthstation S8 Platform, Propel |
| Jazz Pharmaceuticals INC. | $217.19 | 2019-2025 | |
| Organogenesis INC. | $201.10 | 2023-2025 | Novachor, Affinity, Puraply |
| Smith+Nephew, INC. | $172.49 | 2019-2025 | Tula, Halo |
| Preceptis Medical, INC. | $95.13 | 2025 | |
| Stryker Corporation | $93.46 | 2019-2022 | |
| Optinose US, INC. | $82.32 | 2019-2024 | |
| Intersect Ent, INC. | $70.13 | 2020-2021 | |
| Phathom Pharmaceuticals, INC. | $65.04 | 2024-2025 | Voquezna |
| Convatec INC. | $44.75 | 2024-2025 | |
| Itamar Medical INC | $42.22 | 2022 | |
| Alk-Abello, INC | $36.43 | 2020-2023 | Timothy, Standardized, Alternaria Tenuis, Standardized Mite D. Farinae |
| Axsome Therapeutics, INC. | $34.50 | 2022-2023 | Sunosi |
Show all 24 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Cochlear Americas | $33.45 | 2024 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Baha, Osia Osi300 Implant |
| Karl Storz Endoscopy-America | $32.79 | 2019 | |
| Avadel Cns Pharmaceuticals, LLC | $31.68 | 2023-2025 | Lumryz |
| Glaxosmithkline, LLC. | $29.62 | 2023 | Nucala |
| Greer Laboratories, INC. | $21.18 | 2025 | Oralair |
| Astrazeneca Pharmaceuticals Lp | $19.00 | 2025 | Tezspire |
| Resmed Corp | $18.99 | 2019 | |
| Paratek Pharmaceuticals, INC. | $17.09 | 2025 | Xhance |
| Covidien Lp | $13.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Thomas Simpson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.